1. The document provides information on evaluating and managing asthma and COPD. It compares the pathophysiology and characteristics of the two conditions.
2. Key differences include that COPD typically affects larger airways through destruction and fibrosis, while asthma affects smaller airways through bronchial hyperresponsiveness and mucus plugs. COPD is usually caused by smoking and leads to irreversible airway obstruction.
3. Management of both involves reliever medications for acute symptoms and controller medications like inhaled corticosteroids and bronchodilators. Lifestyle changes such as smoking cessation and pulmonary rehabilitation are also important aspects of COPD management.
15. 15
1 As
need
reliever
medicatio
n
Rapid acting β2-agonist ( )
2
Reliever
medicatio
n plus
single
controller
Rapid acting β2-agonist + Low dose ICS
3
Reliever
medicatio
n plus
one or
two
controller
Rapid acting β2-agonist + Low dose ICS + Long actingβ2-agonist
Steroids
( dose steroids medium or high)
Rapid actingβ2-agonist+Medium or high dose
ICS (
Long actingβ2-agonist)
4
Reliever
medicatio
n plus two
or more
controller
Rapid acting β2-agonist+ Medium or high dose ICS+Long acting
β2-agonist
5
Reliever
medicatio
n plus
additional
controller
options
( 4)oral glucocorticoid (lowest dose) / anti-
IgE treatment